Mostrar el registro sencillo del ítem

dc.contributor.authorMalik, Komal
dc.contributor.authorDiaz-Coto, Susana
dc.contributor.authorVillaverde, Maria de la Asunción
dc.contributor.authorMartinez-Camblor, Pablo
dc.contributor.authorNavarro-Rolon, Annie
dc.contributor.authorPujalte, Francisco
dc.contributor.authorDe la Sierra, Alejandro
dc.contributor.authorAlmagro, Pere
dc.date.accessioned2024-04-10T04:02:37Z
dc.date.available2024-04-10T04:02:37Z
dc.date.issued2022
dc.identifier10.2147/COPD.S373853
dc.identifier.issn11769106
dc.identifier.urihttps://hdl.handle.net/20.500.12728/10777
dc.description.abstractBackground: Several mechanisms have been proposed to explain why chronic obstructive pulmonary disease (COPD) impairs the prognosis of coronary events. We aimed to explore COPD variables related to a worse prognosis in patients undergoing percutaneous coronary intervention (PCI). Methods: Patients with an acute coronary event treated by PCI were prospectively included. One month after discharge, clinical characteristics, comorbidities measured with the Charlson index, and prognostic coronary scales (logistic EuroSCORE; GRACE 2.0) were collected. Post-bronchodilator spirometry, arterial stiffness, and serum inflammatory and myocardial biomarkers were measured. Lung plasmatic biomarkers (Surfactant protein D, desmosine, and Clara cell secretory protein-16) were determined with ELISA. COPD was defined by the fixed ratio (FEV1/FVC <70%). Spirometric values were also analyzed as continuous variables using adjusted and non-adjusted ANCOVA analysis. Finally, we evaluated the presence of a respiratory pattern defined by non-stratified spirometric values and pulmonary biomarkers. Results: A total of 164 patients with a mean age of 65 (±10) years (79% males) were included. COPD was diagnosed in 56 (34%) patients (68% previously undiagnosed). COPD patients had a longer smoking history, higher scores on the EuroSCORE (p < 0.0001) and GRACE 2.0 (p < 0.001) scales, and more comorbidities (p = 0.006). Arterial stiffness determined by pulse wave velocity was increased in COPD patients (7.35 m/s vs 6.60 m/s; p = 0.006). Serum values of high sensitive T troponin (p = 0.007) and surfactant protein D (p = 0.003) were also higher in COPD patients. FEV1% remained significantly associated with arterial stiffness and surfactant protein D in the adjusted ANCOVA analysis. In the cluster exploration, 53% of the patients had a respiratory pattern. Conclusion: COPD affects one-third of patients with an acute coronary event and frequently remains undiagnosed. Several mechanisms, including arterial stiffness and SPD, were increased in COPD patients. Their relationship with the prognosis should be confirmed with longitudinal follow-up of the cohort. © 2022 Malik et al.es_ES
dc.description.sponsorshipFundacion Mutua de Terrassa, (FMTBE0128, SEPAR 506-2018)es_ES
dc.language.isoenes_ES
dc.publisherDove Medical Press Ltdes_ES
dc.subjectacute coronary eventes_ES
dc.subjectarterial stiffnesses_ES
dc.subjectchronic obstructive pulmonary diseasees_ES
dc.subjectischaemic heart diseasees_ES
dc.subjectpercutaneous coronary interventiones_ES
dc.subjectsurfactant protein Des_ES
dc.titleImpact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Studyes_ES
dc.typeArticlees_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem